Molina Healthcare, Inc. (MOH)
NYSE: MOH · Real-Time Price · USD
161.21
+3.90 (2.48%)
At close: Aug 13, 2025, 4:00 PM
162.95
+1.74 (1.08%)
After-hours: Aug 13, 2025, 7:04 PM EDT
Molina Healthcare Stock Forecast
Stock Price Forecast
According to 11 professional analysts, the 12-month price target for Molina Healthcare stock ranges from a low of $179 to a high of $414. The average analyst price target of $244.55 forecasts a 51.70% increase in the stock price over the next year.
Price Target: $244.55 (+51.70%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Molina Healthcare stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 0 |
| Buy | 5 | 5 | 5 | 6 | 3 | 3 |
| Hold | 7 | 9 | 9 | 9 | 10 | 9 |
| Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 16 | 16 | 17 | 14 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold Maintains $272 → $184 | Hold | Maintains | $272 → $184 | +14.14% | Jul 29, 2025 |
| UBS | UBS | Hold Maintains $260 → $180 | Hold | Maintains | $260 → $180 | +11.66% | Jul 25, 2025 |
| Truist Securities | Truist Securities | Strong Buy → Hold Downgrades $335 → $180 | Strong Buy → Hold | Downgrades | $335 → $180 | +11.66% | Jul 25, 2025 |
| Barclays | Barclays | Hold Maintains $270 → $186 | Hold | Maintains | $270 → $186 | +15.38% | Jul 25, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades $312 → $210 | Buy → Hold | Downgrades | $312 → $210 | +30.26% | Jul 25, 2025 |
Financial Forecast
Revenue This Year
44.80B
from 39.16B
Increased by 14.40%
Revenue Next Year
47.97B
from 44.80B
Increased by 7.07%
EPS This Year
23.85
from 20.42
Increased by 16.78%
EPS Next Year
27.44
from 23.85
Increased by 15.08%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 47.2B | 51.0B | 54.8B | ||
| Avg | 44.8B | 48.0B | 51.0B | ||
| Low | 42.7B | 44.9B | 46.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 20.4% | 13.8% | 14.2% | ||
| Avg | 14.4% | 7.1% | 6.3% | ||
| Low | 9.2% | 0.1% | -3.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 25.84 | 32.55 | 37.38 | ||
| Avg | 23.85 | 27.44 | 31.27 | ||
| Low | 21.32 | 23.03 | 26.72 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 26.5% | 36.5% | 36.2% | ||
| Avg | 16.8% | 15.1% | 13.9% | ||
| Low | 4.4% | -3.4% | -2.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.